Pharma Capital
CompanyCurrent (p)Volume
Gunsynd (GUN) 0.04 40,990,681
Sarossa (SARS) 1.52 14,021,775
GlaxoSmithKline (GSK) 1643.50 9,187,367
Shire (SHP) 4651.50 3,658,827
Oxford Biomedica (OXB) 5.17 3,213,709
Sareum Holdings (SAR) 0.88 2,788,385
Vectura (VEC) 117.50 2,461,851
GW Pharmaceuticals (GWP) 735.00 2,319,262
ReNeuron Group (RENE) 1.95 1,849,742
Indivior (INDV) 321.00 1,842,486
AstraZeneca (AZN) 5227.00 1,566,224
ValiRx (VAL) 2.40 1,237,487
Summit Therapeutics (SUMM) 180.00 1,077,933
BTG (BTG) 646.00 800,664
Oxford Pharmascience Group (OXP) 1.65 782,928
Motif Bio (MTFB) 32.50 773,256
Hikma Pharmaceuticals (HIK) 1692.00 756,584
SkyePharma (SKP) 443.00 524,876
ECO Animal Health (EAH) 587.50 504,715
Alliance Pharma (APH) 53.25 503,446
Clinigen Group (CLIN) 879.00 414,956
Abcam (ABC) 981.00 296,080
Premaitha Health (NIPT) 10.75 286,002
Quantum Pharma (QP.) 59.75 210,076
Sinclair IS Pharma (SPH) 33.00 209,826
Dechra Pharmaceuticals (DPH) 1869.00 193,017
Vernalis (VER) 18.75 156,470
4d pharma (DDDD) 310.00 150,268
Eden Research (EDEN) 9.88 150,000
Amryt Pharma (AMYT) 26.50 146,657

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.